Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Brain Research. Molecular Brain Research

• Publication date

  1996-09-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0169-328X(96)00081-2PMID 8883943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis

  1995cited by this paper
• Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice.

  1995cited by this paper
• Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells.

  1995cited by this paper
• Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue.

  1995cited by this paper
• Amyotrophic lateral sclerosis: human challenge for neuroscience.

  1995cited by this paper
• Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse.

  1994cited by this paper
• Insulin-like and fibroblast growth factors in spinal cords, nerve roots and skeletal muscle of human controls and patients with amyotrophic lateral sclerosis

  1994cited by this paper
• Elevated insulin-like growth factor (IGF) gene expression in sciatic nerves during IGF-supported nerve regeneration.

  1994cited by this paper
• Growth factor receptors in amyotrophic lateral sclerosis

  1994cited by this paper
• Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis.

  1994cited by this paper
• Insulin-like growth factors cross the blood-brain barrier.

  1994cited by this paper
• Role of insulin-like growth factors in peripheral nerve regeneration.

  1994cited by this paper
• Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4

  1994cited by this paper
• Expression of Insulin-like Growth Factor-I and Related Peptides during Motoneuron Regeneration

  1994cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• Can neurotrophic factors prevent or reverse motoneuron injury in amyotrophic lateral sclerosis?

  1993cited by this paper
• Excitotoxic neuronal cell death in amyotrophic lateral sclerosis.

  1993cited by this paper
• Entorhinal cortex lesion induces differential responses in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in the rat hippocampal formation.

  1993cited by this paper
• Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis.

  1993cited by this paper
• Neurite promoting activity of insulin, insulin-like growth factor I and nerve growth factor on spinal motoneurons is astrocyte dependent.

  1993cited by this paper
• Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival.

  1993cited by this paper
• Activity‐Sensitive Signaling by Muscle‐Derived Insulin‐like Growth Factors in the Developing and Regenerating Neuromuscular System

  1993cited by this paper
• Insulin-like growth factor II increases the rate of sciatic nerve regeneration in rats.

  1993cited by this paper
• Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice.

  1993cited by this paper
• Pathogenic Mechanisms in Sporadic Amyotrophic Lateral Sclerosis

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Alterations in spinal cord excitatory amino acid receptors in amyotrophic lateral sclerosis patients.

  1992cited by this paper
• Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitro.

  1992cited by this paper
• Insulin-like growth factor II stimulates motor nerve regeneration.

  1992cited by this paper
• The downregulation of growth-associated proteins in motoneurons at the onset of synapse elimination is controlled by muscle activity and IGF1

  1992cited by this paper
• Does insulin-like growth factor I (IGF-1) trigger the cell body reaction in the rat sciatic nerve?

  1991cited by this paper
• Abnormalities in the sensory action potential in patients with amyotrophic lateral sclerosis

  1991cited by this paper
• Cytopathology of amyotrophic lateral sclerosis.

  1991cited by this paper
• Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors

  1990cited by this paper
• Insulin-like growth factor I promotes nerve regeneration: an experimental study on rat sciatic nerve.

  1990cited by this paper
• Survival effect of ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in culture: comparison with other neurotrophic factors and cytokines

  1990cited by this paper
• Relationship of insulin-like growth factor II gene expression in muscle to synaptogenesis.

  1989cited by this paper
• Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps

  1989cited by this paper
• Insulin-like growth factor (IGF-1) as a stimulator of regeneration in the freeze-injured rat sciatic nerve.

  1989cited by this paper
• Somatomedin-C is not increased in the serum of patients with amyotrophic lateral sclerosis.

  1988cited by this paper
• Fibroblast growth factor effects on peripheral nerve regeneration in a silicone chamber model

  1988cited by this paper
• Effects of growth hormone treatment on the regeneration of rat sciatic nerve.

  1988cited by this paper
• Rapid axoplasmic transport of insulin-like growth factor I in the sciatic nerve of adult rats

  1987cited by this paper
• Serum insulin-like growth factor-I levels in amyotrophic lateral sclerosis.

  1987cited by this paper
• Insulin-like growth factor I receptors in neuronal and glial cells. Characterization and biological effects in primary culture.

  1987cited by this paper
• Morphometric quantification of the cervical limb motor cells in controls and in amyotrophic lateral sclerosis.

  1979cited by this paper

• Alterations to metabolic hormones in amyotrophic lateral sclerosis and frontotemporal dementia postmortem human tissue

  2024cites this paper
• CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth

  2022cites this paper
• Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration

  2020cites this paper
• Insulin-like growth factor 1 signaling in motor neuron and polyglutamine diseases: From molecular pathogenesis to therapeutic perspectives.

  2020cites this paper
• Amyotrophic lateral sclerosis.

  2019cites this paper
• Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases

  2017cites this paper
• Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis.

  2017cites this paper
• The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

  2016cites this paper
• The role of ALS associated genes and c-Jun in neurodegeneration

  2016cites this paper
• Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease.

  2012cites this paper
• Upregulation of the E3 ligase NEDD4-1 by Oxidative Stress Degrades IGF-1 Receptor Protein in Neurodegeneration

  2012cites this paper
• Insulin-like growth factors in the peripheral nervous system.

  2012cites this paper
• Desarrollo de vectores de terapia génica en enfermedades que afectan al sistema nervioso central: Estudio del fragmento C de la toxina tetánica

  2011cites this paper
• The GH–IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin‐like growth factors and clinical features

  2010cites this paper
• Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson’s disease

  2010cites this paper
• Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis

  2009cites this paper
• Preserved expression of fibroblast growth factor (FGF)-2 and FGF receptor 1 in brain and spinal cord of amyotrophic lateral sclerosis patients

  2009cites this paper
• The insulin-like growth factor-1 axis and its potential as a therapeutic target in central nervous system (CNS) disorders.

  2009cites this paper
• Immunohistochemical localization of insulin-like growth factor binding protein 2 in the central nervous system of SOD1G93A transgenic mice

  2009cites this paper
• Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats.

  2008cites this paper
• Minireview: Insulin-Like Growth Factors in the Peripheral Nervous System

  2008cites this paper
• Transcriptional profile of primary astrocytes expressing ALS‐linked mutant SOD1

  2008cites this paper
• A Novel Purification Method for CNS Projection Neurons Leads to the Identification of Brain Vascular Cells as a Source of Trophic Support for Corticospinal Motor Neurons

  2008cites this paper
• Immunohistochemical study on the distribution of insulin-like growth factor-binding protein 4 in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.

  2008cites this paper
• Insulin-like growth factors in the peripheral nervous system.

  2008cites this paper
• Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.

  2007cites this paper
• Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile rats

  2007cites this paper
• Expression of insulin‐like growth factor‐II and leukemia inhibitory factor antibody immunostaining on the ionized calcium‐binding adaptor molecule 1‐positive microglias in the spinal cord of amyotrophic lateral sclerosis patients

  2007cites this paper
• CHAPTER 19 – VEGF, an Angiogenic Factor with Neurotrophic Activity, Useful for Treatment of ALS?

  2006cites this paper
• Effect of Neuroprotective Drugs on Gene Expression in G93A/SOD1 Mice

  2005cites this paper
• Insulin-like growth factor system in amyotrophic lateral sclerosis.

  2005cites this paper
• Neurotrophic Factors and Amyotrophic Lateral Sclerosis

  2004cites this paper
• The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system.

  2004cites this paper
• Insulin-Like Growth Factors and Nervous System Disorders

  2004cites this paper
• Functional Organization of Dorsal Horn Interneurons

  2004cites this paper
• Immunohistochemical study on the distribution of insulin-like growth factor I (IGF-I) receptor in the central nervous system of SOD1(G93A) mutant transgenic mice.

  2003cites this paper
• Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis.

  2003cites this paper
• Neuroprotective effects of insulin-like growth factor-I (IGF-I) following a penetrating brain injury in rats.

  2003cites this paper
• Amyotrophic Lateral Sclerosis (ALS)

  2003cites this paper
• Expression of IGF-II Receptor in the Spinal Cord of ALS Rats

  2003cites this paper
• Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis

  2002cites this paper
• Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.

  2002cites this paper
• Age-related upregulation of insulin-like growth factor receptor type I in rat cerebellum.

  2002cites this paper
• Insulin‐like growth factor‐II/Mannose‐6‐phosphate receptor in the spinal cord and dorsal root ganglia of the adult rat

  2002cites this paper
• Delayed application of IGF-I and GDNF can rescue already injured postnatal motor neurons

  2001cites this paper
• Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons.

  2001cites this paper
• Effects of short- and long-term rat hind limb immobilization on spinal cord insulin-like growth factor-I and its receptor.

  2001cites this paper
• Additivity and potentiation of IGF-I and GDNF in the complete rescue of postnatal motor neurons

  2001cites this paper
• Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway.

  2000cites this paper
• Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke.

  2000cites this paper
• Golf ball epilepsy

  2000cites this paper
• Cellular aspects of trophic actions in the nervous system.

  1999cites this paper
• Molecular mechanisms regulating motor neuron development and degeneration

  1999cites this paper
• Treatment of Amyotrophic Lateral Sclerosis

  1999cites this paper
• Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis

  1999cites this paper
• The role of neuronal growth factors in neurodegenerative disorders of the human brain.

  1998cites this paper
• Autoradiographic Localization of Growth Factor Receptors in Neuronal Tissues

  1998cites this paper
• Phosphatidylinositol 3‐Kinase: Increased Activity and Protein Level in Amyotrophic Lateral Sclerosis

  1998cites this paper
• Insulin-like growth factor-I: clinical studies.

  1998cites this paper
• The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis

  1998cites this paper
• Abnormalities of protein kinases in neurodegenerative diseases.

  1998cites this paper
• The preclinical rationale for the use of insulin-like growth factor-I in amyotrophic lateral sclerosis.

  1998cites this paper
• rhIGF-I for the Treatment of Neuromuscular Disorders

  1998cites this paper
• Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats.

  1997cites this paper
• Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group.

  1997cites this paper
• Effect of recombinant human insulin-like growth factor-I on progression of ALS

  1997cites this paper
• Presence and differential internalization of two distinct insulin-like growth factor receptors in rat hippocampal neurons.

  1997cites this paper
• Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases.

  1997cites this paper
• The early intracellular signaling pathway for the insulin/insulin-like growth factor receptor family in the mammalian central nervous system

  1996cites this paper
• Amyotrophic lateral sclerosis.

  1995cites this paper